RosenbaumJFTollefsonGD. Fluoxetine. In: SchatzbergAFNemeroffCB, editors. The American Psychiatric Press textbook of psychopharmacology. 3rd ed.Washington (DC): American Psychiatric Press; 2003. pp 231–46.
2.
BolandRJKellerMB. Treatment of depression. In: SchatzbergAFNemeroffCB, editors. The American Psychiatric Press textbook of psychopharmacology. 3rd ed.Washington (DC): American Psychiatric Press; 2003. p 847–64.
3.
SegravesRT. Antidepressant-induced sexual dysfunction. J Clin Psychiatry1998;59(Suppl 4):48–54.
4.
LaumanEOPalikARosenRC. Sexual dysfunction in the United States. JAMA1999;281:537–44.
5.
DordingCMMischoulonDPetersenTJKornbluhRGordonJNierenbergAA, and others. The pharmacologic management of SSRI-induced side effects: A survey of psychiatrists. Ann Clin Psychiatry2002:14:143–7.
6.
GitlinMJSuriRAltshulerLZuckerbrow-MillerJFairbanksL.Bupropion sustained release as a treatment for SSRI-induced sexual side effects. J Sex Marital Ther2002;28:131–8.
7.
FavaMRankinMAAlpertJENierenbergAAWorthingtonJJ. An open trial of oral sildenafil in antidepressant-induced sexual dysfunction. Psychother Psychosom1998;67:328–31.
8.
NurnbergHGLaurielloJHensleyPLParkerLMKeithSJ. Sildenafil for iatrogenic serotonergic antidepressant medication-induced sexual dysfunction in 4 patients. J Clin Psychiatry1999;60(1):33–5.
9.
KeatingGMScottLJ. Vardenafil: A review of its use in erectile dysfunction. Drugs2003;63:2673–703.
10.
GoldsteinIYoungJMFischerJBangerterKSegersonTTaylorT.Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: A multicenter double-blind placebo-controlled fixed-dose study. Diabetes Care2003;26:777–83.
11.
HellstromWJ. Vardenafil: A new approach to the treatment of erectile dysfunction. Curr Urol Rep2003;4:479–87.